Chronic myeloid leukemia (CML) is a proliferative disorder involving the accumulation of early myeloid precursors as a result of the formation of the BCR-ABL1 fusion protein formed by reciprocal translocation of chromosomes 9 and 22103. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.